Neurobiology of Aging
Volume 30, Issue 5 , Pages 731-738 , May 2009

The transcription factor PITX3 is associated with sporadic Parkinson's disease

  • Julia Fuchs

      Affiliations

    • Hertie-Institute for Clinical Brain Research, Department of Neurodegenerative Diseases, University of Tübingen, Otfried-Müller-Strasse 27, 72076 Tübingen, Germany
    • Present address: CNRS UMR 8542, Departement of Biology, École normale supérieure, 46 rue d’Ulm, 75005 Paris, France.
    • These authors contributed equally to this work.
    • ,
  • Jakob C. Mueller

      Affiliations

    • Hertie-Institute for Clinical Brain Research, Department of Neurodegenerative Diseases, University of Tübingen, Otfried-Müller-Strasse 27, 72076 Tübingen, Germany
    • Present address: Max Planck Institute for Ornithology, Department Behavioural Ecology & Evolutionary Genetics, Postfach 1564, 82305 Starnberg (Seewiesen), Germany.
    • These authors contributed equally to this work.
    • ,
  • Peter Lichtner

      Affiliations

    • Institute for Human Genetics, GSF National Research Centre for Environment and Health, Ingolstädter Landstraße 1, 85764 Neuherberg, Germany
    • ,
  • Claudia Schulte

      Affiliations

    • Hertie-Institute for Clinical Brain Research, Department of Neurodegenerative Diseases, University of Tübingen, Otfried-Müller-Strasse 27, 72076 Tübingen, Germany
    • ,
  • Marita Munz

      Affiliations

    • Hertie-Institute for Clinical Brain Research, Department of Neurodegenerative Diseases, University of Tübingen, Otfried-Müller-Strasse 27, 72076 Tübingen, Germany
    • ,
  • Daniela Berg

      Affiliations

    • Hertie-Institute for Clinical Brain Research, Department of Neurodegenerative Diseases, University of Tübingen, Otfried-Müller-Strasse 27, 72076 Tübingen, Germany
    • ,
  • Ullrich Wüllner

      Affiliations

    • Department of Neurology, University of Bonn, 53105 Bonn, Germany
    • ,
  • Thomas Illig

      Affiliations

    • Institute for Epidemiology, GSF National Research Centre for Environment and Health, Ingolstädter Landstraße 1, 85764 Neuherberg, Germany
    • ,
  • Manu Sharma

      Affiliations

    • Hertie-Institute for Clinical Brain Research, Department of Neurodegenerative Diseases, University of Tübingen, Otfried-Müller-Strasse 27, 72076 Tübingen, Germany
    • ,
  • Thomas Gasser

      Affiliations

    • Hertie-Institute for Clinical Brain Research, Department of Neurodegenerative Diseases, University of Tübingen, Otfried-Müller-Strasse 27, 72076 Tübingen, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 7071 2986529; fax: +49 7071 294839.

Received 22 May 2007 ,Revised 2 August 2007 ,Accepted 20 August 2007.

References 

  1. Alberi L, Sgado P, Simon HH. Engrailed genes are cell-autonomously required to prevent apoptosis in mesencephalic dopaminergic neurons. Development. 2004;131(13):3229–3236
  2. Blanchette M, Kent WJ, Riemer C, Elnitski L, Smit AF, Roskin KM, et al. Aligning multiple genomic sequences with the threaded blockset aligner. Genome Res. 2004;14(4):708–715
  3. Conde L, Vaquerizas JM, Ferrer-Costa C, de la Cruz X, Orozco M, Dopazo J. PupasView: a visual tool for selecting suitable SNPs, with putative pathological effect in genes, for genotyping purposes. Nucleic Acids Res. 2005;33:W501–W505(Web Server issue)
  4. Conde L, Vaquerizas JM, Santoyo J, Al-Shahrour F, Ruiz-Llorente S, Robledo M, et al. PupaSNP Finder: a web tool for finding SNPs with putative effect at transcriptional level. Nucleic Acids Res. 2004;32:W242–W248(Web Server issue)
  5. Davis CA, Joyner AL. Expression patterns of the homeo box-containing genes En-1 and En-2 and the proto-oncogene int-1 diverge during mouse development. Genes Dev. 1988;2(12B):1736–1744
  6. de Bakker PI, Yelensky R, Pe’er I, Gabriel SB, Daly MJ, Altshuler D. Efficiency and power in genetic association studies. Nat. Genet. 2005;37(11):1217–1223
  7. Evangelou E, Maraganore DM, Ioannidis JP. Meta-analysis in genome-wide association datasets: strategies and application in Parkinson disease. PLoS ONE. 2007;2:e196
  8. Fahn S. Description of Parkinson's disease as a clinical syndrome. Ann. N.Y. Acad. Sci. 2003;991:1–14
  9. Fearnley JM, Lees AJ. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain. 1991;114(Pt 5):2283–2301
  10. Frantz GD, Weimann JM, Levin ME, McConnell SK. Otx1 and Otx2 define layers and regions in developing cerebral cortex and cerebellum. J. Neurosci. 1994;14(10):5725–5740
  11. Fung HC, Scholz S, Matarin M, Simon-Sanchez J, Hernandez D, Britton A, et al. Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol. 2006;5(11):911–916
  12. Hering R, Petrovic S, Mietz EM, Holzmann C, Berg D, Bauer P, et al. Extended mutation analysis and association studies of Nurr1 (NR4A2) in Parkinson disease. Neurology. 2004;62(7):1231–1232
  13. Hsu SH, Hsieh-Li HM, Huang HY, Huang PH, Li H. bHLH-zip transcription factor Spz1 mediates mitogen-activated protein kinase cell proliferation, transformation, and tumorigenesis. Cancer Res. 2005;65(10):4041–4050
  14. Hudson C, Clements D, Friday RV, Stott D, Woodland HR. Xsox17alpha and -beta mediate endoderm formation in Xenopus. Cell. 1997;91(3):397–405
  15. Hwang DY, Fleming SM, Ardayfio P, Moran-Gates T, Kim H, Tarazi FI, et al. 3,4-dihydroxyphenylalanine reverses the motor deficits in Pitx3-deficient aphakia mice: behavioral characterization of a novel genetic model of Parkinson's disease. J. Neurosci. 2005;25(8):2132–2137
  16. Illig T, Bongardt F, Schopfer A, Holle R, Muller S, Rathmann W, et al. The endotoxin receptor TLR4 polymorphism is not associated with diabetes or components of the metabolic syndrome. Diabetes. 2003;52(11):2861–2864
  17. Kleinjan DA, van Heyningen V. Long-range control of gene expression: emerging mechanisms and disruption in disease. Am. J. Hum. Genet. 2005;76(1):8–32
  18. Krauss S, Maden M, Holder N, Wilson SW. Zebrafish pax[b] is involved in the formation of the midbrain–hindbrain boundary. Nature. 1992;360(6399):87–89
  19. Le WD, Xu P, Jankovic J, Jiang H, Appel SH, Smith RG, et al. Mutations in NR4A2 associated with familial Parkinson disease. Nat. Genet. 2003;33(1):85–89
  20. Maraganore DM, de Andrade M, Elbaz A, Farrer MJ, Ioannidis JP, Kruger R, et al. Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. JAMA. 2006;296(6):661–670
  21. Maraganore DM, de Andrade M, Lesnick TG, Strain KJ, Farrer MJ, Rocca WA, et al. High-resolution whole-genome association study of Parkinson disease. Am. J. Hum. Genet. 2005;77(5):685–693
  22. Mizuta I, Satake W, Nakabayashi Y, Ito C, Suzuki S, Momose Y, et al. Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease. Hum. Mol. Genet. 2006;15(7):1151–1158
  23. Mueller JC, Fuchs J, Hofer A, Zimprich A, Lichtner P, Illig T, et al. Multiple regions of alpha-synuclein are associated with Parkinson's disease. Ann. Neurol. 2005;57(4):535–541
  24. Mueller JC, Lohmussaar E, Magi R, Remm M, Bettecken T, Lichtner P, et al. Linkage disequilibrium patterns and tagSNP transferability among European populations. Am. J. Hum. Genet. 2005;76(3):387–398
  25. Niu TK, Pfeifer AC, Lippincott-Schwartz J, Jackson CL. Dynamics of GBF1, a Brefeldin A-sensitive Arf1 exchange factor at the Golgi. Mol. Biol. Cell. 2005;16(3):1213–1222
  26. Nunes I, Tovmasian LT, Silva RM, Burke RE, Goff SP. Pitx3 is required for development of substantia nigra dopaminergic neurons. Proc. Natl. Acad. Sci. U.S.A. 2003;100(7):4245–4250
  27. Prakash N, Wurst W. Development of dopaminergic neurons in the mammalian brain. Cell Mol. Life Sci. 2006;63(2):187–206
  28. Puelles E, Acampora D, Lacroix E, Signore M, Annino A, Tuorto F, et al. Otx dose-dependent integrated control of antero-posterior and dorso-ventral patterning of midbrain. Nat. Neurosci. 2003;6(5):453–460
  29. Rieger DK, Reichenberger E, McLean W, Sidow A, Olsen BR. A double-deletion mutation in the Pitx3 gene causes arrested lens development in aphakia mice. Genomics. 2001;72(1):61–72
  30. Sandelin A, Wasserman WW, Lenhard B. ConSite: web-based prediction of regulatory elements using cross-species comparison. Nucleic Acids Res. 2004;32:W249–W252(Web Server issue)
  31. Semina EV, Ferrell RE, Mintz-Hittner HA, Bitoun P, Alward WL, Reiter RS, et al. A novel homeobox gene PITX3 is mutated in families with autosomal-dominant cataracts and ASMD. Nat. Genet. 1998;19(2):167–170
  32. Semina EV, Murray JC, Reiter R, Hrstka RF, Graw J. Deletion in the promoter region and altered expression of Pitx3 homeobox gene in aphakia mice. Hum. Mol. Genet. 2000;9(11):1575–1585
  33. Siepel A, Bejerano G, Pedersen JS, Hinrichs AS, Hou M, Rosenbloom K, et al. Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res. 2005;15(8):1034–1050
  34. Simeone A. Genetic control of dopaminergic neuron differentiation. Trends Neurosci. 2005;28(2):62–65discussion 5–6
  35. Simon HH, Saueressig H, Wurst W, Goulding MD, O’Leary DD. Fate of midbrain dopaminergic neurons controlled by the engrailed genes. J. Neurosci. 2001;21(9):3126–3134
  36. Smidt MP, Asbreuk CH, Cox JJ, Chen H, Johnson RL, Burbach JP. A second independent pathway for development of mesencephalic dopaminergic neurons requires Lmx1b. Nat. Neurosci. 2000;3(4):337–341
  37. Smidt MP, Smits SM, Bouwmeester H, Hamers FP, van der Linden AJ, Hellemons AJ, et al. Early developmental failure of substantia nigra dopamine neurons in mice lacking the homeodomain gene Pitx3. Development. 2004;131(5):1145–1155
  38. Smidt MP, van Schaick HS, Lanctot C, Tremblay JJ, Cox JJ, van der Kleij AA, et al. A homeodomain gene Ptx3 has highly restricted brain expression in mesencephalic dopaminergic neurons. Proc. Natl. Acad. Sci. U.S.A. 1997;94(24):13305–13310
  39. Smits SM, Ponnio T, Conneely OM, Burbach JP, Smidt MP. Involvement of Nurr1 in specifying the neurotransmitter identity of ventral midbrain dopaminergic neurons. Eur. J. Neurosci. 2003;18(7):1731–1738
  40. Sohn J, Natale J, Chew LJ, Belachew S, Cheng Y, Aguirre A, et al. Identification of Sox17 as a transcription factor that regulates oligodendrocyte development. J. Neurosci. 2006;26(38):9722–9735
  41. Song DL, Chalepakis G, Gruss P, Joyner AL. Two Pax-binding sites are required for early embryonic brain expression of an Engrailed-2 transgene. Development. 1996;122(2):627–635
  42. Sonnier L, Le Pen G, Hartmann A, Bizot JC, Trovero F, Krebs MO, et al. Progressive loss of dopaminergic neurons in the ventral midbrain of adult mice heterozygote for Engrailed1. J. Neurosci. 2007;27(5):1063–1071
  43. Steffens M, Lamina C, Illig T, Bettecken T, Vogler R, Entz P, et al. SNP-based analysis of genetic substructure in the German population. Hum. Hered. 2006;62(1):20–29
  44. Tan EK, Chung H, Zhao Y, Shen H, Chandran VR, Tan C, et al. Genetic analysis of Nurr1 haplotypes in Parkinson's disease. Neurosci. Lett. 2003;347(3):139–142
  45. Torlakovic E, Slipicevic A, Robinson C, DeCoteau JF, Alfsen GC, Vyberg M, et al. Pax-5 expression in nonhematopoietic tissues. Am. J. Clin. Pathol. 2006;126(5):798–804
  46. Urbanek P, Wang ZQ, Fetka I, Wagner EF, Busslinger M. Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell. 1994;79(5):901–912
  47. van den Munckhof P, Luk KC, Ste-Marie L, Montgomery J, Blanchet PJ, Sadikot AF, et al. Pitx3 is required for motor activity and for survival of a subset of midbrain dopaminergic neurons. Development. 2003;130(11):2535–2542
  48. Varnum DS, Stevens LC. Aphakia, a new mutation in the mouse. J. Hered. 1968;59(2):147–150
  49. Wallen A, Zetterstrom RH, Solomin L, Arvidsson M, Olson L, Perlmann T. Fate of mesencephalic AHD2-expressing dopamine progenitor cells in NURR1 mutant mice. Exp. Cell Res. 1999;253(2):737–746
  50. Westerberg R, Mansson JE, Golozoubova V, Shabalina IG, Backlund EC, Tvrdik P, et al. ELOVL3 is an important component for early onset of lipid recruitment in brown adipose tissue. J. Biol. Chem. 2006;281(8):4958–4968
  51. Xu PY, Liang R, Jankovic J, Hunter C, Zeng YX, Ashizawa T, et al. Association of homozygous 7048G7049 variant in the intron six of Nurr1 gene with Parkinson's disease. Neurology. 2002;58(6):881–884
  52. Zhao X, Claude A, Chun J, Shields DJ, Presley JF, Melancon P. GBF1, a cis-Golgi and VTCs-localized ARF-GEF, is implicated in ER-to-Golgi protein traffic. J. Cell Sci. 2006;119(Pt 18):3743–3753
  53. Zheng K, Heydari B, Simon DK. A common NURR1 polymorphism associated with Parkinson disease and diffuse Lewy body disease. Arch. Neurol. 2003;60(5):722–725

PII: S0197-4580(07)00348-X

doi: 10.1016/j.neurobiolaging.2007.08.014

Neurobiology of Aging
Volume 30, Issue 5 , Pages 731-738 , May 2009

Article Tools